ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - July 1959

Decade

Year

Issue

April 2016, Vol 73, No. 4, Pages 313-412

In This Issue of JAMA Psychiatry

Highlights

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(4):313. doi:10.1001/jamapsychiatry.2015.1618
Viewpoint

Restrict the Recruitment of Involuntarily Committed Patients for Psychiatric Research

Abstract Full Text
JAMA Psychiatry. 2016;73(4):317-318. doi:10.1001/jamapsychiatry.2015.3117

This Viewpoint discusses advancement in the laws regarding the recruitment of involuntarily committed patients and makes suggestions for improvement in the future.

Editorial

Moderators of Remission in Patients With Late-Life Depression: Where Do We Go Next?

Abstract Full Text
JAMA Psychiatry. 2016;73(4):319-320. doi:10.1001/jamapsychiatry.2015.3458

The Course of Illness After Initial Diagnosis of Major Depression

Abstract Full Text
JAMA Psychiatry. 2016;73(4):321-322. doi:10.1001/jamapsychiatry.2015.3457

Assortative Mating—A Missing Piece in the Jigsaw of Psychiatric Genetics

Abstract Full Text
JAMA Psychiatry. 2016;73(4):323-324. doi:10.1001/jamapsychiatry.2015.3204

Physician-Assisted Death for Patients With Mental Disorders—Reasons for Concern

Abstract Full Text
JAMA Psychiatry. 2016;73(4):325-326. doi:10.1001/jamapsychiatry.2015.2890

Rigid, Inflexible Approach Results in No Recommendation for Autism Screening

Abstract Full Text
JAMA Psychiatry. 2016;73(4):327-328. doi:10.1001/jamapsychiatry.2016.0143
Original Investigation

Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(4):329-336. doi:10.1001/jamapsychiatry.2015.3447

This analysis of a randomized clinical trial tests the moderating role of pretreatment executive function, severity of anxiety, and severity of medical comorbidity in remission of treatment-resistant late-life depression after aripiprazole augmentation.

Indicators for Remission of Suicidal Ideation Following Magnetic Seizure Therapy in Patients With Treatment-Resistant Depression

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(4):337-345. doi:10.1001/jamapsychiatry.2015.3097

This study evaluates cortical inhibition as a possible indication of remission of suicidal ideation following magnetic seizure therapy in patients with treatment-resistant depression.

Heterogeneity in 10-Year Course Trajectories of Moderate to Severe Major Depressive Disorder: A Danish National Register-Based Study

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(4):346-353. doi:10.1001/jamapsychiatry.2015.3365

This study uses civil and psychiatric national registers to evaluate patterns and correlates in 10-year trajectories associated with the diagnosis of major depressive disorder in a Danish population.

Patterns of Nonrandom Mating Within and Across 11 Major Psychiatric Disorders

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(4):354-361. doi:10.1001/jamapsychiatry.2015.3192

This cohort study using Swedish population registers quantifies the nature and extent of nonrandom mating, within and across a broad range of psychiatric conditions, at the population level.

Euthanasia and Assisted Suicide of Patients With Psychiatric Disorders in the Netherlands 2011 to 2014

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(4):362-368. doi:10.1001/jamapsychiatry.2015.2887

This study describes patient characteristics and practices of euthanasia and assisted suicide among Dutch patients with psychiatric disorders.

Analyzing the Role of MicroRNAs in Schizophrenia in the Context of Common Genetic Risk Variants

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(4):369-377. doi:10.1001/jamapsychiatry.2015.3018

This study examines the role of microRNAs in the context of genetic variation associated with schizophrenia.

Internet-Assisted Parent Training Intervention for Disruptive Behavior in 4-Year-Old Children: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(4):378-387. doi:10.1001/jamapsychiatry.2015.3411

This study determines whether an Internet-assisted intervention using whole-population screening that targets the most symptomatic 4-year-old children is effective at 6 and 12 months after the start of treatment.

Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(4):388-395. doi:10.1001/jamapsychiatry.2015.3229

This cohort study uses national survey data to examine associations between cannabis use and risk of mental health and substance use disorders in the general US adult population.

Mediation of Developmental Risk Factors for Psychosis by White Matter Microstructure in Young Adults With Psychotic Experiences

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(4):396-406. doi:10.1001/jamapsychiatry.2015.3375

This cross-sectional study compares white matter myelination and microstructure in individuals with vs without psychotic experiences and examines neurodevelopmental variables associated with the experiences.

Neuroscience and Psychiatry

Multimodal Applications of Transcranial Magnetic Stimulation for Circuit-Based Psychiatry

Abstract Full Text
JAMA Psychiatry. 2016;73(4):407-408. doi:10.1001/jamapsychiatry.2015.3127

This Neuroscience and Psychiatry article reports on transcranial magnetic stimulation, a noninvasive neuromodulation technique that applies powerful and rapidly changing magnetic fields over the surface of the skull and generates targeted electrical currents in the brain, leading to neuronal action potentials.

How MicroRNAs Are Involved in Splitting the Mind

Abstract Full Text
JAMA Psychiatry. 2016;73(4):409-410. doi:10.1001/jamapsychiatry.2015.3144

This commentary provides an introduction to the role of microRNAs in the nervous system and outlines their potential involvement in the pathophysiology of schizophrenia.

Comment & Response

Group-Level Symptom Networks in Depression

Abstract Full Text
JAMA Psychiatry. 2016;73(4):411. doi:10.1001/jamapsychiatry.2015.3103

Group-Level Symptom Networks in Depression—Reply

Abstract Full Text
JAMA Psychiatry. 2016;73(4):411-412. doi:10.1001/jamapsychiatry.2015.3157
Correction

Error in Title

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(4):412. doi:10.1001/jamapsychiatry.2016.0024

Error in Affiliation

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(4):412. doi:10.1001/jamapsychiatry.2016.0282

Error in Text and Table

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(4):412. doi:10.1001/jamapsychiatry.2016.0426

Incorrect Definition in Abstract

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(4):412. doi:10.1001/jamapsychiatry.2016.0663
JAMA Psychiatry Masthead

JAMA Psychiatry

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(4):316. doi:10.1001/jamapsychiatry.2015.1619
×